Browsing Tag
CEND-
1 post
CEND-1 Offers Hope in Advanced Pancreatic Cancer
Chemotherapy combined with the CEND-1 cyclic peptide showed promising efficacy, and was well tolerated as a first-line treatment, for patients with metastatic pancreatic cancer, researchers reported. In a phase I study of 29 patients evaluable for efficacy, 59% (95% CI 39-77) responded to the combination of CEND-1 -- a novel 9-amino acid cyclic peptide that…